Patricia Maria Rodriguez

3PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 29, 2023
The Possible Role of Matrix Metalloprotienase-2 in the Relapse in Patients with Stage II Colon Cancer Treated by Curative Surgery.

Nigel P Murray, Ricardo Villalon, Socrates Aedo

|Feb 28, 2022
Improvement in the Neutrophil-Lymphocyte Ratio after Combined Fluorouracil, Leucovorina and Oxaliplatino based (FOLFOX) Chemotherapy for Stage III Colon Cancer is Associated with Improved Minimal Residual Disease and Outcome.

Nigel P Murray, Ricardo Villalon, Dan Hartmann

|Sep 02, 2021
Improvement in immune dysfunction after FOLFOX chemotherapy for Stage III colon cancer is associated with improved minimal residual disease prognostic subtype and outcome.

Nigel P Murray, Ricardo Villalon, Dan Hartmann

Pageof 1

Frequent Collaborators

3 joint publications

Nigel P Murray

3 joint publications

Ricardo Villalon

3 joint publications

Dan Hartmann

2 joint publications

Socrates Aedo